Login to Your Account

Disappointing Data for Bowel Resection Drug Sink Tranzyme

By Catherine Shaffer
Staff Writer

Tuesday, March 13, 2012

Tranzyme Pharma Inc.'s drug ulimorelin failed to perform in a trial for bowel resection recovery acceleration, according to top-line results released Monday.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription